FDA issued a Warning Letter to Essex Institutional Review Board, Inc on 7/26/2011 as a result of this inspection.
483 Essex Institutional Review Board Mar 2011

483 Essex Institutional Review Board Mar 2011

$119 - Not in Stock

FDA investigators audited the Essex Institutional Review Board - Lebanon, NJ, United States facility and issued inspectional observations (via FDA 483) on 21 Mar 2011.

Product details

  • Category: Human Drugs
  • Inspection end: 21 Mar 2011
  • Location: Lebanon, United States
  • FEI: 2246448
Order